LHV finantsportaal

Foorum Investeerimine

Börsipäev 18. oktoober

Kommentaari jätmiseks loo konto või logi sisse

  • Teisipäeval sulgusid Tallinna (+0.44%) ja Riia (+0.13%) indeksid plusspoolel ning Vilniuse (-0.17%) indeks lõpetas alustatust madalamal. Põhinimekirja aktsiatega tehti 318 tehingut kogumahus 516 tuhat eurot, millest Tallinna börsi käive moodustas 292 tuhat eurot ning Vilniuse börsi käive 197 tuhat eurot ning tehingute arvud olid vastavalt 161 ja 139.

    Kõige suuremas mahus kaubeldud aktsia oli Tallinna Vesi (+0.81%) käibega 88 tuhat eurot ning tehinguid tehti kokku 39. Tallink Grupp (0.00%) käibeks kujunes 21 tehinguga (kaks plokktehingut EUR 1.075 x 9774; EUR 1.080 x 5000) 55 tuhat eurot. Šiaulių bankas (-0.52%) aktsiaga tehti 25 tehingut kogumahus 53 tuhat eurot.

    Enim tõusid eile PRFoods (+11.03%, käive EUR 15k), HansaMatrix (+4.78%, käive EUR 2k), Panevėžio statybos trestas (+1.77%, käive EUR 13k). Suurimad langejad olid Grindeks (-2.95%, käive EUR 200), Klaipėdos nafta (-1.36%, käive EUR 27k), Vilkyškių pieninė (-1.33%, käive EUR 27k).

    Homme avalikustavad Telia Lietuva ja Baltika kolmanda kvartali tulemused
  • UnitedHealthi ja Johnson & Johnsoni oodatust paremad majandustulemused kergitasid kogu tervishoiusektorit, osutudes eile ühtlasi peamiseks veduriks, mis aitas Dow Jones indeksil käia esmakordselt üle 23 000 punkti. Kuigi Dow sulgumine leidis aset madalamal, märkis 0,2% tõus siiski uut rekordit ning samuti tegi 0,1%ga värske tipu S&P 500 indeks. Nasdaq lõpetas sisuliselt ilma muutuseta. Euroopas andsid aktsiaturud ära esialgse positiivsuse, sulgudes Stoxx 600 näol -0,3% punases.

    USA majade ehitajate kindlustunde indeks hüppas oktoobris nelja punkti võrra 68 punktile, ületades analüütikute 64punktist ootust ning saavutades kõrgeima taseme alates maist. NAHBi sõnul on ehitajad taastumas tormide järgsest ehmatusest, aga silmas tuleb pidada orkaanide pikaajalisi tagajärgi nagu näiteks materjalide hinnatõus ja tööjõu puudus.

    Hiina president Xi Jinping ei pakkunud Kommunistliku Partei kongressi avakõnes suuri üllatusi, keskendudes senistele saavutustele ja pikaajalistele eesmärkidele. Rahvusvahelise olukorra kohta sõnas ta, et globaalsel majanduslikul taastumisel puudub jõulisus ning esile tõu regionaalsete konfliktide ja turbulentsi rohket esinemist. Kuid sellele vaatamata avaldas kindlustunnet ehitada 2020. aastaks valmis mõõdukalt jõuka ühiskonna, mis Bloombergi hinnangu kohaselt eeldab lähiaastail 6,5% SKP kasvueesmärgi säilitamist.

    Majandusuudistest on täna laual Suurbritannia augusti ja septembri tööturu näitajad ning Ühendriikides kinnisvaraturu septembri esimesed aktiivsusnäitajad. Mario Draghi esinemisele võib samuti tähelepanu langeda, kuigi kõne keskendub euroala struktuursetele reformidele ning tõenäoliselt väga palju järgmise nädala EKP istungiks turuosalistele vihjeid ei paku.

    11.10 Mario Draghi esineb
    11.30 Suurbritannia tööturu statistika (august, september)
    15.00 FEDi Kaplan ja Dudley esinevad
    15.30 USA alustatud elamuehitused (september)
    15.30 USA väljastatud ehitusload (september)
    17.15 EKP Coeure esineb
    21.00 FEDi Beige Book
  • Bitcoini viimase tõusuga pole Bitcoin Investment Trust kaasa läinud, tänu millele on kohati üle 100% kasvanud preemia kahanenud 30% peale
  • Suurbritannia töötu abiraha taotluste arv kasvas septembris 1,7 tuhande võrra pärast -0,2K langust augustis, Kolme kuu keskmine töötuse määr püsis augustis ootuspäraselt 4,3% peal ning keskmise nädalapalga kasv boonuseid arvestamata aeglustus -0,1pp võrra 2,1%le (oodati 2,0%).
  • Isegi kui korrektsioon tuleb, siis JPMorgan arvates ei saa langused olema suured

    * Stock investors globally should be prepared for a market pullback but not yet positioned for a more substantial downside that usually comes with recessions, JPMorgan Asset Management says in note.
    * “There is enough opportunity to keep investors engaged, but our optimism is tempered by higher valuations and the potential for increased risk appetite to eventually lead to excessive risk-taking”
    * Global economic recovery will continue; not expecting a recession (even for the now late-cycle U.S. economy) over the next couple of years
    * In Europe, corporate profits are growing for the first time in six years; further euro strength is a potential headwind
    * The impact of unwinding of quantitative easing on capital markets is unknown; taking some comfort in the still relatively attractive valuations of stocks vs. bonds
  • Gapping up
    In reaction to strong earnings/guidance:

    IBM +5.8%, ADTN +4.8%, SVU +4.2%, IBKR +3.2%, UFPI +2.6%, ABT +1.7%, NAVI +1.2%, OMAB +1.2%, PZG +1.1%, CP +1%
    Other news:
    PLX +35.3% (announces an Ex-US license and collaboration agreement with Chiesi Farmaceutici for pegunigalsidase alfa)
    SSKN +31.4% (thinly traded; announces agreement with MedResults Network that will enhance sales efforts of Nordlys and STRATAPEN )
    SPPI +31.4% (reports new data for Poziotinib; demonstrates evidence of significant antitumor activity)
    RXDX +31.4% (reports data for Entrectinib demonstrated a 78% and 69% confirmed ORR)
    TROV +17.7% (announces 'positive' data from preclinical research demonstrating synergy of PCM-075)
    DRIO +16.1% (receives CE Mark for its Lightning-enabled version of the Dario Blood Glucose Monitoring System )
    BNTC +11.9% (confirms new patent relating to the Company's hepatitis B program has been issued in the United States)
    LTBR +11.7% (received a Notice of Allowance in the China for another key patent relating to its metallic fuel design)
    HCLP +11.1% (resumes distribution for the third quarter of 2017 and announces unit buyback program -- declared a quarterly cash distribution of $0.15 per unit on all common units, approved a unit buyback program of up to $100 million)
    ABUS +7.8% (announces a collaboration and license agreement w/ Gritstone Oncology)
    LPCN +5.1% (FDA has scheduled the Bone, Reproductive and Urologic Drugs Advisory Committee meeting on January 10, 2018 to discuss the New Drug Application for TLANDO)
    FMSA +4% (HCLP sympathy)
    INO +3.4% (was initiated after the close with Outperform rating and $11 tgt at RBC Capital Mkts)
    PRKR +3.3% (enters into common stock purchase agreement with Aspire Capital for a private placement of 312,500 shares of common stock at $1.60 per share)
    JUNO +2.7% (enters a license agreement for the Trianni Mouse
    SLCA +2.2% (HCLP sympathy)
    CVS +1.5% (announces five-year agreement with Anthem (ANTM) to provide services to support IngenioRx)
    FGEN +1.3% (announces that the CFDA has accepted the co's recently submitted New Drug Application for registration of roxadustat)
    QURE +1.1% (presents preclinical data on AMT-130)
    ALNY +1.1% (announces licensing agreement with Vir Biotechnologyfor the development and commercialization of RNAi therapeutics for infectious diseases)
    PYPL +0.9% (following JPM/WePay news)
    Analyst comments:
    LSCC +4.5% (upgraded to Buy from Hold at Jefferies)
    GPRO +4.4% (upgraded to Buy from Neutral at Longbow)
    FTNT +3.1% (upgraded to Buy from Hold at Deutsche Bank)
    SYNT +2.7% (upgraded to Outperform from Mkt Perform at William Blair)
    MGA +2.4% (upgraded to Buy from Underperform at BofA/Merrill)
    EQIX +1.8% (upgraded to Overweight from Equal Weight at Barclays)
    MRK +1.6% (upgraded to Buy from Neutral at Citigroup)
    MET +1.2% (initiated on the Conviction Buy List at Goldman)
    Gapping down
    In reaction to disappointing earnings/guidance:

    MOBL -10.5%, SCSS -5.3%, MTG -3.1%, FOGO -2.5%, HBHC -1.9%, MTB -1.3%, CREE -0.6%, ASML -0.5%
    Other news:
    AKTX -18.8% (to offer and sell American Depositary Shares in an underwritten public offering;)
    HUSA -7.2% (files ~12.178 mln share common stock offering by selling stockholders )
    RDCM -3.5% ( to offer its ordinary shares in an underwritten public offering)
    TPX -1.7% (following SCSS earnings)
    CHEF -1.2% (CFO John D. Austin resigns effective November 10 )
    RIG -1% (Transocean awarded a two-year, $106 mln contract plus three one-year priced options with a subsidiary of BHP Billiton, expected to commence in 2Q18)
    BHP -0.8% (reports Q3 operational update; all production and unit cost guidance remains unchanged for the 2018 financial year)
    Analyst comments:
    CMG -2.7% (downgraded to Underperform from Neutral at BofA/Merrill)
    ULTA -2.6% (downgraded to Neutral from Overweight at Piper Jaffray)
    HAWK -2.1% (downgraded to Neutral from Buy at Mizuho)
    W -1.8% (Hearing Oppenheimer out in the premarket with a note suggesting traffic may be soft to the website)
    MGM -0.8% (downgraded to Hold from Buy at Stifel)

    Briefing.com
  • USA kinnisvaraturu näitajad oodatust nõrgemad, mida osaliselt mõjutasid ilmaolud. Eile avaldatud ehitajate kindlustunde järgi peaks oktoober tooma positiivsemaid arenguid

    US Building Permits Change Sep: 1215K (est 1245K; prev R 1272K)
    -Building Permits (M/M) Sep: -4.50% (est -2.10%; prev R 3.40%)


    US Housing Starts Change Sep: 1127K (est 1175K; prev R 1183K)
    -Housing Starts (M/M) Sep: -4.70% (est -0.40%; prev R -0.20%)

Teemade nimekirja